《2017年意大利共识指南：类风湿性关节炎患者HBV感染的管理》摘译

2017-11-05 临床肝胆病杂志.2017.33(11):21-24.

意大利风湿病学学会(SIR)联合意大利传染病和热带疾病研究学会(SIMIT)共同发布了类风湿性关节炎患者乙肝病毒感染的管理指南，HBV感染是许多国家最主要的公共健康问题，本文主要针对类风湿性关节炎患者HBV感染的管理提供共识建议。

中文标题：

发布机构：

发布日期：

2017-11-05

简要介绍：

意大利风湿病学学会(SIR)联合意大利传染病和热带疾病研究学会(SIMIT)共同发布了类风湿性关节炎患者乙肝病毒感染的管理指南，HBV感染是许多国家最主要的公共健康问题，本文主要针对类风湿性关节炎患者HBV感染的管理提供共识建议。

译者：温州医科大学附属第一医院吴锦露陈晔（译）陈永平（审校），温州医科大学第一临床医学院潘文婷（译）

拓展指南：与类风湿性关节炎相关指南：

有关类风湿性关节炎更多指南

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=057981c00151e549, title=《2017年意大利共识指南：类风湿性关节炎患者HBV感染的管理》摘译, enTitle=, guiderFrom=临床肝胆病杂志.2017.33(11):21-24., authorId=null, author=, summary=意大利风湿病学学会(SIR)联合意大利传染病和热带疾病研究学会(SIMIT)共同发布了类风湿性关节炎患者乙肝病毒感染的管理指南，HBV感染是许多国家最主要的公共健康问题，本文主要针对类风湿性关节炎患者HBV感染的管理提供共识建议。 , cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Sun Nov 05 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=意大利风湿病学学会(SIR)联合意大利传染病和热带疾病研究学会(SIMIT)共同发布了类风湿性关节炎患者乙肝病毒感染的管理指南，HBV感染是许多国家最主要的公共健康问题，本文主要针对类风湿性关节炎患者HBV感染的管理提供共识建议。 译者：温州医科大学附属第一医院吴锦露陈晔（译）陈永平（审校），温州医科大学第一临床医学院潘文婷（译） 拓展指南：与类风湿性关节炎相关指南： <ul><li><a href="//www.sandwebs.com/guideline/show_article.do?id=18ccf1c001a41e99" title="2017 意大利共识指南：类风湿性关节炎患者丙肝病毒感染的管理" target=_blank>2017 意大利共识指南：类风湿性关节炎患者丙肝病毒感染的管理</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=45a241c001389196" title="2016 EULAR建议：应用合成的和生物类改善病情的抗风湿药物治疗类风湿性关节炎（更新版）" target=_blank>2016 EULAR建议：应用合成的和生物类改善病情的抗风湿药物治疗类风湿性关节炎（更新版）</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=f666d1c0013160b4" title="2016 NICE技术评估指南：Certolizumab pego用于治疗TNFα抑制剂治疗反应不敏感类风湿性关节炎（TA415）" target=_blank>2016 NICE技术评估指南：Certolizumab pego用于治疗TNFα抑制剂治疗反应不敏感类风湿性关节炎（TA415）</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=26d551c00129915e" title="2016 EULAR建议：类风湿性关节炎以及其他形式的炎症性关节病患者心血管疾病风险的管理 " target=_blank>2016 EULAR建议：类风湿性关节炎以及其他形式的炎症性关节病患者心血管疾病风险的管理 </a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=ad38d1c001022ea3" title="2013年 EULAR 生物合成制剂类抗风湿药物治疗类风湿性关节炎建议（更新版）" target=_blank>2013年 EULAR 生物合成制剂类抗风湿药物治疗类风湿性关节炎建议（更新版）</a></li> 更多信息请点击：<a href="//www.sandwebs.com/guideline/list.do?q=%E7%B1%BB%E9%A3%8E%E6%B9%BF%E6%80%A7%E5%85%B3%E8%8A%82%E7%82%8E" target=_blank>有关类风湿性关节炎更多指南</a></ul>, tagList=[TagDto(tagId=2259, tagName=类风湿性关节炎), TagDto(tagId=7995, tagName=乙肝病毒感染)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6722, appHits=243, showAppHits=0, pcHits=4745, showPcHits=2085, likes=166, shares=6, comments=12, approvalStatus=1, publishedTime=Thu Nov 09 23:55:56 CST 2017, publishedTimeString=2017-11-05, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Nov 09 23:55:56 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 16:49:25 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=《2017年意大利共识指南：类风湿性关节炎患者HBV感染的管理》摘译)])

《2017年意大利共识指南：类风湿性关节炎患者HBV感染的管理》摘译

下载请点击：

评论区 (9)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=808260, encodeId=0df980826089, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf3b3037337, createdName=841975707, createdTime=Wed Aug 12 20:27:39 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260459, encodeId=ed3a26045965, content=学习学习.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat Nov 11 08:35:27 CST 2017, time=2017-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260132, encodeId=5566260132c5, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Fri Nov 10 00:25:26 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260131, encodeId=67df260131ae, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Fri Nov 10 00:25:21 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260130, encodeId=eb8e26013093, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Fri Nov 10 00:25:18 CST 2017, time=2017-11-10, status=1, ipAttribution=)]
2020-08-12 841975707

学习学习

128 0
[GetPortalCommentsPageByObjectIdResponse(id=808260, encodeId=0df980826089, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf3b3037337, createdName=841975707, createdTime=Wed Aug 12 20:27:39 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260459, encodeId=ed3a26045965, content=学习学习.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat Nov 11 08:35:27 CST 2017, time=2017-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260132, encodeId=5566260132c5, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Fri Nov 10 00:25:26 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260131, encodeId=67df260131ae, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Fri Nov 10 00:25:21 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260130, encodeId=eb8e26013093, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Fri Nov 10 00:25:18 CST 2017, time=2017-11-10, status=1, ipAttribution=)]
2017-11-11 1dd8c52fm63(暂无匿称)

学习学习.继续关注

124 0
[GetPortalCommentsPageByObjectIdResponse(id=808260, encodeId=0df980826089, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf3b3037337, createdName=841975707, createdTime=Wed Aug 12 20:27:39 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260459, encodeId=ed3a26045965, content=学习学习.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat Nov 11 08:35:27 CST 2017, time=2017-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260132, encodeId=5566260132c5, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Fri Nov 10 00:25:26 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260131, encodeId=67df260131ae, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Fri Nov 10 00:25:21 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260130, encodeId=eb8e26013093, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Fri Nov 10 00:25:18 CST 2017, time=2017-11-10, status=1, ipAttribution=)]
2017-11-10 xiaotao112411

学习学习学习

148 0
[GetPortalCommentsPageByObjectIdResponse(id=808260, encodeId=0df980826089, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf3b3037337, createdName=841975707, createdTime=Wed Aug 12 20:27:39 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260459, encodeId=ed3a26045965, content=学习学习.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat Nov 11 08:35:27 CST 2017, time=2017-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260132, encodeId=5566260132c5, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Fri Nov 10 00:25:26 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260131, encodeId=67df260131ae, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Fri Nov 10 00:25:21 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260130, encodeId=eb8e26013093, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Fri Nov 10 00:25:18 CST 2017, time=2017-11-10, status=1, ipAttribution=)]
2017-11-10 xiaotao112411

学习学习学习

129 0
[GetPortalCommentsPageByObjectIdResponse(id=808260, encodeId=0df980826089, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf3b3037337, createdName=841975707, createdTime=Wed Aug 12 20:27:39 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260459, encodeId=ed3a26045965, content=学习学习.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat Nov 11 08:35:27 CST 2017, time=2017-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260132, encodeId=5566260132c5, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Fri Nov 10 00:25:26 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260131, encodeId=67df260131ae, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Fri Nov 10 00:25:21 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260130, encodeId=eb8e26013093, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Fri Nov 10 00:25:18 CST 2017, time=2017-11-10, status=1, ipAttribution=)]
2017-11-10 xiaotao112411

学习学习学习

136 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

感染指南

《2017年意大利共识指南：类风湿性关节炎患者HBV感染的管理》摘译

相关指南

科室

工具

服务